Skip to content
Screener

LifeStance Health Group LFST Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$403.5MBeat by $16.0M
EPS$0.04Beat by $0.03
Revenue estimate$387.5M
EPS estimate$0.01

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$431.4M
EPS estimate$0.03

Financials

Q1 2026

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04—

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2.44B-4.8%
Enterprise value$2.72B-6.5%
P/E105.1×—
P/S1.6×-0.4×

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

FAQ

When did LifeStance Health Group report Q1 2026 earnings?
LifeStance Health Group (LFST) reported Q1 2026 earnings on May 7, 2026 before market open.
What were LifeStance Health Group's Q1 2026 revenue and EPS?
LifeStance Health Group reported revenue of $403.5M and eps of $0.04 for Q1 2026.
Did LifeStance Health Group beat estimates in Q1 2026?
Revenue beat the consensus estimate of $387.5M by $16.0M. EPS beat the consensus estimate of $0.01 by $0.03.
How did LifeStance Health Group's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.2% from $333.0M a year earlier and eps grew 2062.2% from $0.00.
Where can I find LifeStance Health Group's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-209709) and the 10-Q periodic report (0001193125-26-211814) directly on SEC EDGAR. The filing index links above go to sec.gov.